Inventiva Sa (IVA)

Inventiva Sa (IVA) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $770M; returns 1 day +3.1%, 1 week +26.2%, 1 year -36.8%.

Inventiva S.A. is a French clinical-stage biopharmaceutical company specializing in the research and development of small molecule therapies targeting fibrosis, oncology, and rare diseases.

Groups IVA belongs to

• Biotechnology
• Clinical Stage Biotech
• Clinical Stage Biopharma
• NASH
• Liver Disease
• Fibrosis
• Metabolic Disorders
• Rare Diseases
• Biopharmaceutical
• Healthcare

IVA financial model: income statement, cash flow and balance sheet